Table 3.
Distribution of the 5 Rs of consumption of colistin and polymyxin B.
| Variables | Pre-ASP Implementation (n) | 2016–2017 (n) | 2017–2018 (n) | 2018–2019 (n) | 2019–2020 (n) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C | PB | Total | C | PB | Total | C | PB | Total | C | PB | Total | C | PB | Total | |
| 738 | 34 | 772 | 315 | 95 | 410 | 358 | 128 | 486 | 317 | 63 | 380 | 389 | 28 | 417 | |
| Right indication | 613 | 30 | 643 (83%) | 225 | 57 | 282 (69%) | 349 | 122 | 471 (97%) | 313 | 61 | 374 (98%) | 377 | 28 | 405 (97%) |
| Right drug | 488 | 21 | 509 (66%) | 215 | 55 | 270 (66%) | 334 | 117 | 451 (93%) | 308 | 59 | 367 (96%) | 375 | 27 | 402 (96%) |
| Loading dose required | 642 | 34 | 676 (87%) | 292 | 95 | 387 (94%) | 329 | 121 | 450 (92%) | 291 | 60 | 351 (92%) | 299 | 28 | 327 (78%) |
| Right loading dose given | 46 | 0 | 46 (6%) | 135 | 72 | 207 (53%) | 245 | 103 | 348 (77%) | 262 | 51 | 313 (89%) | 282 | 17 | 299 (91%) |
| Right maintenance dose given | 164 | 27 | 191 (25%) | 212 | 84 | 296 (72%) | 307 | 120 | 427 (88%) | 287 | 58 | 345 (91%) | 360 | 27 | 387 (93%) |
| Right frequency | 174 | 29 | 203 (26%) | 256 | 90 | 346 (84%) | 341 | 125 | 466 (96%) | 311 | 63 | 374 (98%) | 382 | 28 | 410 (98%) |
| Right duration | 247 | 14 | 261 (34%) | 242 | 72 | 314 (77%) | 325 | 114 | 439 (90%) | 305 | 59 | 364 (96%) | 378 | 28 | 406 (97%) |
C = colistin; PB = polymyxin B.